Laptop computer showing pharmaceutical webinar on screen

Image source: Royal Pharmaceutical Society

Sponsored • Live webinar

The start of a new chapter for Martindale: The Complete Drug Reference

Watch live on: 9th July 2024
Starts: 11:00 BST (10:00 UTC, 15:00 PDT)
Duration: 1 hour


Health and industry professionals globally rely on Martindale: The Complete Drug Reference for concise and specific detail to identify and understand drugs, herbals, and other pharmaceutical substances. 

In this live webinar, hosted by Account Manager Morgane Brun, Catherine Cadart, and Alison Brayfield, co-editors of Martindale: The Complete Drug Reference will discuss the evolution of Martindale: The Complete Drug Reference, including a live demonstration on MedicinesComplete.

During this webinar you will:

  • Learn about the additional content that is available online 
  • See how to search intuitively
  • Find out about the links to other products on MedicinesComplete 



Speakers:

Catherine Cadart
Co-editor of Martindale: The Complete Drug Reference and Head of Content (Process and Performance) 

Alison Brayfield
Co-editor of Martindale: The Complete Drug Reference and Head of Content (Standards and Training) 


Source: Royal Pharmaceutical Society

04.07.2024

More on the subject:

Related articles

Photo

News • Promising trial results from Spain

Clot-dissolving drug after thrombectomy may improve stroke recovery

Even after a blood clot is removed from a large brain artery via thrombectomy, administering the thrombolytic drug alteplase to the area may improve stroke recovery, a new trial from Spain shows.

Photo

News • Study finds faster regain than ending diet programmes

GLP-1 discontinuation: weight-loss drugs work – until you stop

Drawbacks of GLP-1 discontinuation: People tend to regain weight rapidly after stopping weight-loss drugs - and faster than after ending behavioural weight loss programmes - according to new research.

Photo

Article • Hengrui Pharma charts its global strategy at ESMO

Meet the Chinese company advancing European oncology

Hengrui, one of China's leading pharmaceutical companies, is preparing to bring its cancer therapies to international markets. At the ESMO congress in Berlin, Yuting (Shelley) Liu, Head of China…

Subscribe to Newsletter